Hypoxia and anemia: effects on tumor biology and treatment resistance (Q36090924)

12 August 2017

1 reference

title

Hypoxia and anemia: effects on tumor biology and treatment resistance (English)

1 reference

12 August 2017

0 references

1

Peter Vaupel

1 reference

12 August 2017

Arnulf Mayer

2

1 reference

12 August 2017

1 February 2005

1 reference

Transfusion Clinique et Biologique

12 August 2017

1 reference

12 August 2017

12

1 reference

12 August 2017

1

1 reference

12 August 2017

5-10

1 reference

A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology

12 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Regulation of cell proliferation under extreme and moderate hypoxia: the role of pyrimidine (deoxy)nucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Hypoxia induces pivotal tumor angiogenesis control factors including p53, vascular endothelial growth factor and the NFkappaB-dependent inducible nitric oxide synthase and cyclooxygenase-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Oxygen regulation of gene expression: a study in opposites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Tyrosine phosphorylation of I kappa B alpha activates NF kappa B through a redox-regulated and c-Src-dependent mechanism following hypoxia/reoxygenation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Hypoxic Stress Proteins: Survival of the Fittest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Hypoxia--a key regulatory factor in tumour growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Molecular analysis of selected cell cycle regulatory proteins during aerobic and hypoxic maintenance of human ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

The response of c-jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1 alpha dependent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Transcriptional response to hypoxia in human tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

HIF-1 and tumor progression: pathophysiology and therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Targeting HIF-1 for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

A pathway of neuronal apoptosis induced by hypoxia/reoxygenation: roles of nuclear factor-kappaB and Bcl-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Treatment resistance of solid tumors: role of hypoxia and anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

Tumor hypoxia and malignant progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2004.11.005

10.1016/J.TRACLI.2004.11.005

7 January 2021

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15814285